Evidence map›Paper›PMID 30341240›Full record

ArticleBioscience reports2018

Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.

Yue Jing, Yan Yang, Fengyao Hao, Yuxian Song, Xiaoxin Zhang, Ye Zhang, Xiaofeng Huang, Qingang Hu, Yanhong Ni

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yue JingCentral Laboratory, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
Yan YangDepartment of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
Fengyao HaoDepartment of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
Yuxian SongCentral Laboratory, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
Xiaoxin ZhangCentral Laboratory, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
Ye ZhangDepartment of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
Xiaofeng HuangDepartment of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
Qingang HuDepartment of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China niyanhong12@163.com qghu@nju.edu.cn.
Yanhong NiCentral Laboratory, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China niyanhong12@163.com qghu@nju.edu.cn.ORCID 0000-0002-5427-3667
Nanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Squamous CellCell Line, TumorCell ProliferationDisease-Free SurvivalFemaleFibroblastsGene Expression Regulation, NeoplasticHumansKi-67 AntigenMaleMiddle AgedMouth NeoplasmsNeoplasm InvasivenessNeoplasm StagingTreatment OutcomeKi-67 AntigenMKI67 protein, humanfibroblast like cellsimmunohistochemistryKi67OSCCprognostic markertumor cells

Identifiers

PMID30341240
PMCPMC6246770
OpenAlexW2897140849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.